Clinical Trial Update: Study of UB-312 in Healthy Participants and Parkinson's Disease Patients [Phase 1]

View source ↗

Summary

A Phase 1 study of UB-312 in healthy participants and Parkinson's disease patients has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinsonism

Drugs mentioned

• UB-312

Snippet

Sponsor: United Neuroscience Ltd. | Conditions: Parkinson's Disease, Parkinsonism | Phase 1 | Status: COMPLETED | Results posted: 2025-03-06